DP Production Base — Taizhou Biopharma


Taizhou Biopharma supports end-to-end DP R&D and production from preclinical development, registration batch manufacturing, to commercial production.

 

Siwei Pharma

Floor area:Approx. 120,000 m2

 

Quality Management:Establishing a comprehensive quality management system and processes, committed to continuously meeting the relevant requirements of China GMP, EU GMP, and FDA CGMP. We have successfully passed the registration site inspections and GMP compliance checks by the national and provincial authorities, as well as the GMP compliance inspection by the UK Medicines and Healthcare products Regulatory Agency.

 

Dosage forms:We plan to produce a wide range of dosage forms, including solid and liquid dosage forms and powders for injection.

Siwei Pharma

Production Equipment  

Siwei Pharma

Business Collaboration

Innovative Drug CDMO Services

Established Business Services(API)

Human Resources

Join Us

Jiuzhou

LinkedIn

License

Powered by 300.cn

Business Collaboration

Innovative Drug CDMO Services

Established Business Services(API)

Human Resources

Join Us




[Multiple]Interested business area:
Small Molecule CDMO Services
CDMO-Preparations
CDMO-Polypeptide
Generic drug Service
Registration & Regulatory Service
Animal Health Services